Popular Articles

Simulating Medical Situations Helps Students Learn, Retain Basic Science Concepts
Simulating medical scenarios helps medical students learn and retain vital information, according to a new study done by researchers at Wake Forest University School of Medicine.
generic viagra online
Obama Highlights U.S. Commitment To Reducing Maternal Mortality, HIV/AIDS In Address To Africa
In a speech before the Ghanaian Parliament, President Obama on Saturday reiterated U.S. support for public health programs that will reduce maternal mortality and the spread of HIV/AIDS in Africa, the New York Times reports. The speech, which was televised across the continent, focused on international relations with Africa and empowering African nations to address problems (Baker, New York Times, 7/12).In a portion of the speech about strengthening public health, Obama said that there has been "enormous progress ... in parts of Africa" in recent years. He continued, "Far more people are living productively with HIV/AIDS, and getting the drugs they need. But too many still die from diseases that shouldn"t kill them." He added, "When children are being killed because of a mosquito bite, and mothers are dying in childbirth, then we know that more progress must be made." Obama said that "incentives often provided by donor nations" often compel doctors and nurses to "go overseas, or work for programs that focus on a single disease," which "creates gaps in primary care and basic prevention." He also said that Africans must "make responsible choices that prevent the spread of disease, while promoting public health in their communities and countries."Obama noted that the U.S. has committed $63 billion "to meet these challenges." He added that the U.S. will not "confront illnesses in isolation" but instead "invest in public health systems that promote wellness and focus on the health of mothers and children" (AP/USA Today, 7/11). Obama also visited a women"s clinic to highlight U.S-backed programs to fight infant and maternal mortality (New York Times, 7/12).
News of the day
WHO Calling For Free Spectacles In World Economy Drive
International development agency Sightsavers International supports the World Health Organisation"s (WHO) call for the distribution of low-cost interventions such as spectacles to help boost the global economy which loses billions of dollars each year due to visual impairments.
Medical Devices

Evidence Challenges Effectiveness Of Embryo Screening For Older Women

There is growing evidence that a procedure for identifying chromosomal abnormalities in embryos prior to in vitro fertilization is ineffective at helping older women become pregnant, the Wall Street Journal reports. The procedure -- known as pre-implantation genetic screening, or PGS -- is performed in dozen of U.S. fertility clinics and sometimes marketed to older women as a way to increase the odds of a healthy live birth. PGS involves extracting a single cell from a six-cell embryo and inspecting it for chromosomal abnormalities known as aneuploidies; unaffected embryos can then be implanted through IVF. Women older than age 35 have a higher risk of aneuploidies, in which embryos have fewer or more than the usual number of 23 pairs of chromosomes. Aneuploidies can trigger early miscarriage or certain genetics conditions, such as Down syndrome. Most medical experts agree that embryo screening is capable of significantly reducing the risk of Down syndrome and other serious chromosome-related illnesses. However, evidence from several studies increasingly suggests that the procedure does not increase older women"s chances of healthy live births. The American Society for Reproductive Medicine released an initial opinion about PGS in 2007, saying that available evidence does not support the use of embryo screening to increase live birth rates in older women. Andrew La Barbera, scientific director of the society, said, "Since that time, there have been several more trials that have reached the same conclusion." Another shortcoming is that most clinics can only test for fewer than half of the 23 chromosomes, meaning that many defects can go undetected. However, medical experts say that the use of PGS has increased in the two years since ASRM issued its recommendations. According to the Journal, PGS can add more than $2,000 to the roughly $10,000 cost of one IVF cycle. Very few health insurers cover PGS, though some pay for IVF. Some experts contend that studies showing a lack of clinical benefit from PGS do not use more efficient biopsy techniques that can prevent damage to the embryo. Santiago Munne, scientific director for Reprogenetics, said that the treatment is "effective." In a 2007 study, Munne and colleagues used PGS to reduce the rate at which patients miscarried. However, the chances of a woman getting pregnant largely were unchanged, which the authors said could be attributed to the small number of study participants (Naik, Wall Street Journal, 6/1). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):